The PRISMAP+ project will take over from the PRISMAP project of 2022–2025. The project seeks to lead development towards the upscaling of the production of medical radionuclides in the form of novel production technology, new purification methods and proof-of-concept investigations, showing the development of new treatments from test bench to patient care.
PRISMAP+ will be given the floor during the EANM Congress to present its objectives and ongoing activities and, importantly, engage directly with participants and discuss its role in advancing access to innovative medical radionuclides across Europe.
The session will be held on Sunday, October 18, from 9:30–10:15 at the Austria Center in Vienna. Join the consortium in room 0.11-12 on level 0, close to the main entrance. You may find it listed on the EANM website (Click the EU Affairs Track panel).
Don’t miss this session if you’re attending the congress!